Cardinal Health (NYSE:CAH) announced that it entered into a strategic collaboration with Palantir Technologies (NYSE:PLTR). The partnership pairs the companies to design a solution to give health systems and hospitals dynamic purchase decision insights. These insights help them quickly improve their bottom line. Dublin, Ohio-based Cardinal Health plans to integrate this solution into Foundry, Palantir’s…

Eli Lilly (NYSE:LLY) announced today that it plans to invest an additional $450 million at a North Carolina manufacturing facility. Lilly expects the investment to create at least 100 new jobs at the Research Triangle Park, North Carolina, plant. Its expansion includes additional parenteral filling, device assembly and packaging capacity. Indianapolis-based Lilly said this expansion supports…

Baxter (NYSE:BAX) today unveiled a strategic roadmap for its future that includes potential plans for its BioPharma Solutions (BPS) business. The company’s plans include a simplified commercial and manufacturing footprint, according to a news release. The company also intends to improve its capital structure. That includes a review of strategic alternatives for its BioPharma Solutions…

Pfizer (NYSE:PFE) shares ticked up before hours on third-quarter results that topped the consensus forecast. Shares of PFE ticked up 3.7% at $48.29 apiece before the market opened today. The New York-based pharmaceutical giant posted profits of $8.6 billion. That amounts to $1.51 per share on sales of $22.6 billion for the three months ended…

Generic versions of the Takeda’s (NYSE:TAK) ADHD drug Adderall (amphetamine and dextroamphetamine) continue to be in short supply as demand for it has surged. Both instant-release and extended-release versions of mixed amphetamine salts have been affected by the shortages. A central supplier of the drug in the U.S., Teva (NYSE:TEVA), says labor shortages related to packaging…

Novartis announced today that it intends to separate Sandoz into a new, publicly traded standalone company through a 100% spinoff. The spinoff of the generics and biosimilars division of Novartis aims to maximize shareholder value by creating the top European generics company and a global leader in biosimilars, according to a news release. Such a…

Medication adherence is often low for people who are transitioning out of a hospital setting. Such patients may have received a starter dose during a visit to an emergency room or an overnight hospital stay but fail to pick up medication in a pharmacy after that. “It’s a key pain point. There can be as…

Senate Finance Committee Chair Ron Wyden (D-Oregon) wrote a letter demanding compliance from Merck and Abbott. The letter demands that Merck and Abbott complay with the Senate Finance Committee’s investigation into the tax practices of Big Pharma. According to a news release from the Senate Finance Committee, the two companies have, to this point, “stonewalled”…

The U.S. Department of Health and Human Services (HHS) has said it would make available an additional 144,000 doses of the Jynneos vaccine doses available to states and jurisdictions. Bavarian Nordic A/S (OMX:BAVA) is the manufacturer of the vaccine. Jynneos won FDA approval for both smallpox and monkeypox in 2019. There have been approximately 700…

Federal officials have announced that the clinics across the country would vaccinate individuals with presumed exposure to the monkeypox virus. Earlier, the U.S. had reserved the vaccine for individuals who had confirmed exposure to the virus.  The U.S. has confirmed a preference for the Jynneos vaccine from Bavarian Nordic A/S (OMX:BAVA).  In May, Bavarian Nordic entered…